Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
9th Technical Conference of CSCEC Middle East: Redefining Modern Construction with Revolutionary Methods 2025-12-11 16:36
Youdao 2025 Annual General Meeting of Shareholders 2025-12-11 16:30
Nexteer Builds on Growth Momentum at 2025 Global Strategy Summit in Suzhou, China 2025-12-11 15:56
Yiren Digital Wins "Technology Innovation Leadership Award for Listed Companies" at the 23rd China's Financial Annual Champion Awards 2025-12-11 15:40
9th Technical Conference of CSCEC Middle East: Redefining Modern Construction with Revolutionary Methods 2025-12-11 14:44
Yuans Technology: NVIDIA's Exclusive "Golden Key" to AI Server Infrastructure 2025-12-11 13:13
ODE TO NOBLE LABORERS 2025-12-11 11:24
Noah Holdings Hosts Global Black Diamond Summit, Highlights Vision for AI-Driven Global Wealth Management Future 2025-12-11 11:21
Tencent Cloud Risk Solutions: Leader in the Asia-Pacific Anti-fraud Market 2025-12-11 10:00
Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025 2025-12-11 09:53
/DISREGARD RELEASE: Risen Energy Co., Ltd./ 2025-12-11 02:39
Creality Unveils Scan-to-CAD Workflow Through New QUICKSURFACE Partnership 2025-12-11 02:00
Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006 2025-12-10 22:05
China Premiere of 'Avatar: Fire and Ash' Highlight of 7th HIIFF 2025-12-10 20:37
NaaS Technology Inc. Regains Compliance with Nasdaq Minimum Market Value of Listed Securities Requirement 2025-12-10 20:00
Manycore Tech Unveils LuxReal: A 3D AI Content Creation Product Enhancing "Spatial Consistency" in AI Video 2025-12-10 19:53
CNFINANCE ANNOUNCES THE RESULTS OF ITS EXTRAORDINARY GENERAL MEETING 2025-12-10 19:15
ORGE CO LTD Accelerates Global Expansion With Full-Scale Entry Into Chinese Market 2025-12-10 18:43
Professor Youmin Xi honoured with University of Liverpool Fellowship 2025-12-10 18:01
Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment 2025-12-10 17:15